NewGenIvf Limited is a comprehensive fertility services provider principally in Asia helping couples and individuals obtain access to fertility treatments. NewGenIvf, formerly known as A SPAC I Acquisition Corp., is based in NEW YORK.
| Revenue (Most Recent Fiscal Year) | $5.43M |
| Net Income (Most Recent Fiscal Year) | $-0.52M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | -- |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.18 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -- |
| Net Margin (Trailing 12 Months) | -- |
| Return on Equity (Trailing 12 Months) | -- |
| Return on Assets (Trailing 12 Months) | -- |
| Current Ratio (Most Recent Fiscal Quarter) | 2.21 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.17 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.39 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $-146.02 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | -- |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Common Shares Outstanding | 2.15M |
| Free Float | 1.47M |
| Market Capitalization | $3.90M |
| Average Volume (Last 20 Days) | 0.28M |
| Beta (Past 60 Months) | -0.06 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 31.80% |
| Percentage Held By Institutions (Latest 13F Reports) | 66.24% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |